Project Grant R03AR082449
- This Project Grant award from the National Science Foundation (NSF) Division of Materials Research, under the Mathematical and Physical Sciences program (CFDA 47.049), provides $322,382 to the University of Connecticut Health Center (UCHC) from September 1, 2023 through August 31, 2026. The goals of this collaborative research project are to use computer modeling and high-energy synchrotron X-ray diffraction experiments to better understand how the incorporation of cobalt (Co) and chromium...
- This Project Grant awarded by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041) supports research to understand how human bone tissue dynamically adapts at the nanoscale level under various loading conditions. The $719,538 award to the Trustees of the University of Pennsylvania, made on May 1, 2024, will investigate the real-time rearrangement and deformation of the nanoscale components of healthy and osteoporotic bone tissue when subjected to cyclic loading....
- Federal Project Grant Award Summary Emory University received a $663,901 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, with a completion date of July 31, 2030. The research project investigates the mechanisms by which the intestinal microbiome and specific immune cells enhance fracture healing in humans. The study focuses...
- Federal Project Grant Award Summary The Ohio State University received a $787,500 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on August 15, 2025, with a completion date of July 31, 2027. This research project investigates the effect of age-related changes in macrophage polarization and post-injury immune response on fracture healing outcomes in elderly patients. The primary deliverable is biomedical research directed toward...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $449,538 Project Grant to the University of California, San Francisco on August 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative, titled "Zinc Supplementation in SCD: A Precursor to the Think Zinc for Bones Trial," investigates zinc supplementation as a therapeutic intervention to address early-onset bone morbidity in patients with sickle...
- Federal Cooperative Agreement Summary The National Institute on Aging (NIA) awarded the University of Oregon a $886,403 Cooperative Agreement on September 15, 2025, under the Aging Research program (CFDA 93.866) to develop and validate bone-targeted nanoparticles designed to accelerate fracture healing in aging populations. The research initiative addresses a significant clinical gap by developing the first non-surgical therapeutic to improve fracture repair outcomes. The nanoparticles utilize a...
- This $672,394.58 project grant from the National Institutes of Health's National Institute of Dental and Craniofacial Research Oral Diseases and Disorders Research program (CFDA 93.121) supports the development of a crosslinkable tissue particle implant for regenerating craniofacial bone. Led by Leefa Biotech LLC, the one-year award aims to demonstrate improved bone regeneration in critical-size cranial bone defects using the implant compared to the current standard of care. If successful, the...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Delaware a $1.2 million Project Grant (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) on September 24, 2025, with completion targeted for August 31, 2030. This translational validation study will develop and deploy next-generation magnetic resonance imaging (MRI) methods for early detection and prediction of bone fracture healing outcomes....
- Advanced Molecular Healix Inc. received a $296,256 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective June 1, 2025 through May 31, 2027. The grant funds research and development of a novel therapeutic strategy utilizing hypoxia-inducible factor-1 alpha (HIF-1A) messenger RNA (mRNA) to enhance pedicle flap survival in surgical wound reconstruction. The...
- Federal Project Grant Award Summary This Project Grant, awarded July 15, 2025, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $169,344 in federal funding to the University of California, Davis through June 30, 2030. The award supports mechanistic research investigating systemic and local immunomodulation of fracture healing in polytrauma patients, addressing a...
THERAPEUTIC POTENTIAL OF SYSTEMIC AND LOCALIZED ZINC DELIVERY FOR MODULATING FRACTURE REPAIR - BONE FRACTURES ARE COMMON INJURIES THAT IMPACT MILLIONS OF PEOPLE EACH YEAR, AND POORLY HEALED FRACTURES CAUSE IMPAIRED MOBILITY, LONG-TERM NURSING CARE, OR EVEN PREMATURE DEATH. IT IS KNOWN THAT CONTROLLED MECHANICAL LOADING CAN IMPROVE THE QUALITY AND SPEED OF FRACTURE REPAIR, BUT OUR UNDERSTANDING OF MECHANO- THERAPEUTICS IS STILL UNDERDEVELOPED. RECENT RESEARCH HAS INDICATED THAT ZINC MAY PLAY A FUNDAMENTAL ROLE IN THE EVOLUTION OF FRACTURE REPAIR. ZINC IS KNOWN TO STIMULATE NEW BONE FORMATION, PRESERVE BONE MASS, AND REGULATE APOPTOSIS. IMPORTANTLY, INTRACELLULAR ZINC HOMEOSTASIS MUST BE CAREFULLY COORDINATED TO REGULATE UPTAKE, EXCRETION, AND INTRACELLULAR STORAGE/TRAFFICKING. IT IS BELIEVED THAT ZINC MAY BE MECHANOSENSITIVE; HOWEVER, THE RELATIONSHIPS BETWEEN MECHANICAL LOADING, ZINC HOMEOSTASIS, AND FRACTURE HEALING REMAIN UNCLEAR. THIS PROJECT WILL GENERATE PRELIMINARY DATA REGARDING THE RELATIONSHIPS BETWEEN MECHANOTRANSDUCTION IN REGENERATIVE CELLS AND ESTABLISH LINKS BETWEEN MECHANICAL LOAD TRANSFER AND INTRACELLULAR ZINC HOMEOSTASIS IN BONE FRACTURES. OUR GLOBAL HYPOTHESIS IS THAT THE COMBINATION OF ZINC WITH MECHANICAL LOADING WILL LEAD TO SYNERGISTIC BONE HEALING RESPONSES. IN AIM 1, WE WILL EXTEND OUR EXISTING K25 STUDY WITH AN IN VIVO RAT FEMORAL OSTEOTOMY MODEL AND DETERMINE CHANGES IN BONE HEALING CAUSED BY ZINC DELIVERY AND LOAD TRANSFER. SPRAGUE DAWLEY RATS WILL UNDERGO FEMORAL OSTEOTOMY AND RECONSTRUCTION. MECHANICAL LOADS ACROSS THE CALLUS WILL BE CONTROLLED WITH EITHER RIGID LOCKING PLATES (0-3% STRAIN, LOW LOAD ACROSS FRACTURE) OR MORE COMPLIANT LOCKING PLATES (10-15% STRAIN, HIGH LOAD ACROSS FRACTURE). ZINC LEVELS IN ANIMALS WILL BE MANIPULATED SYSTEMICALLY (THROUGH DIET) AND LOCALLY (IMPLANTATION OF A NON-LOADBEARING INTRAMEDULLARY NAIL). WE HYPOTHESIZE THAT THE COMBINATORY APPLICATION OF MECHANICAL LOADS AND ZINC DELIVERY WILL LEAD TO SYNERGISTIC IMPROVEMENTS IN BONE HEALING THAT ARE DEMONSTRATED BY FASTER AND MORE ROBUST DEVELOPMENT OF CALLUS. CHANGES IN BONE HEALING WILL BE QUANTIFIED WITH MICRO-CT IMAGING, BIOMECHANICAL TESTING, HISTOLOGY, AND QPCR. IN AIM 2, WE WILL DEFINE THE CAUSAL RELATIONSHIPS BETWEEN ZINC DELIVERY, LOAD TRANSFER, ZINC STORAGE/TRAFFICKING, AND OSTEOBLAST FORMATION IN AN IN VITRO CELL CULTURE MODEL. HERE, WE WILL USE CELL CULTURE TECHNIQUES TO EXAMINE THE FATE OF HUMAN MESENCHYMAL STEM CELLS. WE HYPOTHESIZE THAT ZINC-RICH CELLS PLATED ON STIFF, SMOOTH SURFACES WILL ELICIT IMPROVED OSTEOBLASTIC PROLIFERATION AND SUPERIOR CALCIUM MATRIX FORMATION. THESE EXPERIMENTS WILL YIELD FUNDAMENTAL NEW UNDERSTANDING INTO THE MECHANISMS BY WHICH CELLS RECEIVE AND RESPOND TO MECHANICAL STIMULI AND PROVIDE FOUNDATIONAL DATA FOR LONG-TERM DEVELOPMENT OF ZINC-AUGMENTED MECHANO-THERAPEUTICS. CHARACTERIZING THESE RELATIONSHIPS MAY HAVE IMMENSE IMPLICATIONS FOR CELLULAR MECHANOBIOLOGY AND DEVELOPMENT OF MECHANO-THERAPEUTIC APPROACHES FOR BONE REGENERATION AND REPAIR.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $96.8k | 3/4/26 | ||
| Not listed | $4.7k | 3/4/26 | ||
| Not listed | ($97k) | 3/4/26 | ||
| Not listed | $0 | 1/19/26 | ||
| Not listed | $0 | 1/19/26 |